• 1
    Litwin MS, Hays RD, Fink A et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995; 273: 129135
  • 2
    Potosky AL, Harlan LC, Stanford JL et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 1999; 91: 17191724
  • 3
    Potosky AL, Legler J, Albertsen PC et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2000; 92: 15821592
  • 4
    Sanda MG, Dunn RL, Michalski J et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 12501261
  • 5
    Donabedian A. The quality of care. How can it be assessed? JAMA 1988; 260: 17431748
  • 6
    Jayadevappa R, Schwartz JS, Chhatre S, Wein AJ, Malkowicz SB. Satisfaction with care: a measure of quality of care in prostate cancer patients. Med Decis Making 2010; 30: 234245
  • 7
    Cleary PD, McNeil BJ. Patient satisfaction as an indicator of quality care. Inquiry 1988; 25: 2536
  • 8
    Kahn KL, Malin JL, Adams J, Ganz PA. Developing a reliable, valid, and feasible plan for quality-of-care measurement for cancer: how should we measure? Med Care 2002; 40: III7385
  • 9
    Cooperberg MR, Broering JM, Litwin MS et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol 2004; 171: 13931401
  • 10
    Lubeck DP, Litwin MS, Henning JM et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1996; 48: 773777
  • 11
    Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473483
  • 12
    Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993; 2: 217227
  • 13
    Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 1998; 36: 10021012
  • 14
    Greenberg DB, Kornblith AB, Herndon JE et al. Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971–1988: predictors for later psychologic distress. Cancer 1997; 80: 19361944
  • 15
    Hill JM, Kornblith AB, Jones D et al. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer 1998; 82: 208218
  • 16
    Sloan JA, Dueck A. Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials. J Biopharm Stat 2004; 14: 7396
  • 17
    Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582592
  • 18
    Hall JA, Feldstein M, Fretwell MD, Rowe JW, Epstein AM. Older patients' health status and satisfaction with medical care in an HMO population. Med Care 1990; 28: 261270
  • 19
    Lubeck DP, Litwin MS, Henning JM, Mathias SD, Bloor L, Carroll PR. An instrument to measure patient satisfaction with healthcare in an observational database: results of a validation study using data from CaPSURE. Am J Manag Care 2000; 6: 7076
  • 20
    Cooperberg MR, Broering JM, Carroll PR. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst 2009; 101: 878887
  • 21
    Hoffman RM, Hunt WC, Gilliland FD, Stephenson RA, Potosky AL. Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. Cancer 2003; 97: 16531662
  • 22
    Abraham NE, Makarov DV, Laze J, Stefanovics E, Desai R, Lepor H. Patient centered outcomes in prostate cancer treatment: predictors of satisfaction up to 2 years after open radical retropubic prostatectomy. J Urol 2010; 184: 19771981
  • 23
    Fowler FJ Jr, Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology 1995; 45: 10071013
  • 24
    Carvalhal GF, Smith DS, Ramos C et al. Correlates of dissatisfaction with treatment in patients with prostate cancer diagnosed through screening. J Urol 1999; 162: 113118
  • 25
    Mohler J, Bahnson RR, Boston B et al. NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw 2010; 8: 162200
  • 26
    Barocas DA, Cowan JE, Smith JA Jr, Carroll PR. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. J Urol 2008; 180: 13301334